Ageronix SA
Ageronix SA, public limited company in Carouge (GE), pharmaceuticals. Registration active in the commercial register since 2013. Latest publication: Sept. 2, 2021. UID CHE-208.392.325.
Ageronix develops Alpha-1 Antitrypsin-based therapeutics for rare neurological disorders and Alzheimer's disease. Its lead development program targets Charcot-Marie-Tooth disease, with additional programs in Alzheimer's disease and broader neurodegeneration.1
Commercial register
- Legal form
- Public limited company
- Registered office
- c/o ABCYS BUSINESS & CONSULTING Sàrl rue du Tir-au-Canon 4, 1227 Carouge GE
- Share capital
- CHF 100,000
- UID
- CHE-208.392.325
- Registered since
- 2013
- Former names
- Atlas Biotechnology SA
- Registered purpose (original language)
- commerce, distribution, fabrication et développement de produits pharmaceutiques essentiellement à l'étranger (cf. statuts pour but complet).
Similar companies
- Avrion Therapeutics SA Lausanne Scientific research and development
- Asceneuron SA Eysins Scientific research and development
- AC Immune SA Ecublens (VD) Manufacture of basic pharmaceutical products
- ND BioSciences SA Epalinges Scientific research and development
- Atopia Therapeutics SA Genève Scientific research and development
- Addex Therapeutics Ltd Plan-les-Ouates Financial service activities, except insurance and pension funding
A free account opens every company that looks like Ageronix SA, and what they have in common. Create a free account
Register publications
-
Atlas Biotechnology SA, à Carouge (GE), CHE-208.392.325 (FOSC du 02.04.2020, p. 0/1004865087). Nouvelle raison sociale: Ageronix SA. Statuts modifiés le 26.08.2021.
-
Atlas Biotechnology SA, à Carouge (GE), CHE-208.392.325 (FOSC du 03.08.2016, p. 0/2986109). L'administratrice Zhukovsky Galina, nommée présidente signe désormais individuellement. L'administrateur Zhukovsky Nikolay, jusqu'ici président, signe désormais collectivement à deux.
1 This information was estimated by machine learning and may contain errors.